Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/5/26 16:58 | 5/1/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Li Yang | CA | O | Exec. VP | 2 | M.d | 53 | 8.86 | 0 | 6 | 50 | 18 | D | ||||||||||||||
5/5/26 16:58 | 5/4/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Li Yang | CA | O | Exec. VP | 2 | S.d | -53 | 8.86 | 0 | -6 | 18 | D | |||||||||||||||
5/5/26 16:54 | 5/1/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Williams Charles O | CA | O | COO | 2 | M.d | 68 | 8.86 | 0 | 8 | 86 | 17 | D | ||||||||||||||
5/5/26 16:54 | 5/4/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Williams Charles O | CA | O | COO | 2 | S.d | -68 | 8.86 | 0 | -8 | 17 | D | |||||||||||||||
5/5/26 16:51 | 5/1/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Parker Craig C | CA | DO | CEO | 2 | M.d | 151 | 8.86 | 0 | 17 | 17 | D | |||||||||||||||
5/5/26 16:51 | 5/4/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Parker Craig C | CA | DO | CEO | 2 | S.d | -151 | 8.86 | 0 | -17 | 17 | D | |||||||||||||||
3/25/26 20:02 | 3/23/26 | SRZN | Health | BioPrd | Biological Products, (No Diag | Tcg Crossover Gp Ii, LLC | CA | T | 2 | P.m | 4,233 | 24.77 | 0 | 171 | 30 | 737 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |